mainly dedicated to the process of kidney allocation, Remaining problems aiming at an optimal proportion between justice and efficiency [1]-the medical ethical criteria.
Computer-modelled allocation programmes by themAdditionally, the allocation programme had to be selves, however, will not solve the waiting problem. supported by the vast majority of the renal transplant Attention should be paid to (i) equal access and to programmes involved, and to be perceived as fair and standardized listing practices, i.e. an equal starting equitable by all potential transplant candidates and point for all candidates, and (ii) the definition and society. Whereas in earlier times the allocation algojustification of the criterion of 'urgency' in renal transrithms and their adjustments were made by common plantation. The impact of the changing donor kidney sense, intuition and scientific progress, nowadays one quality, as kidney donation criteria are more and more advocates the use of computer simulation studies, liberalized, is difficult to anticipate. In this respect, which are more capable of predicting the outcome of controlled pilot projects might be the only appropriate a particular system and/or proposed change [2, 3] .
solution. Finally, the transplant physician should be aware of the chances of selection for any transplant candidate. What will the theoretical number of kidney
The new allocation system of Eurotransplant offers be if case restrictions are made on donor age, HLA-match requirement, etc.? With regard to these In March 1996, the international organ exchange items, new rules and concepts have been worked out organisation, Eurotransplant [ET ] , switched to a new in the ET organ exchange organisation. kidney allocation system that was based on the kidney allocation computer model study of Wujciak and Opelz [4] . The basic model -a point system with a limited Eligibility criteria and minimal listing criteria for number of allocation factors -was tailored to the renal transplantation: new concept -new rule for actual ET situation without changing the original waiting time?
goals; prevention of long waiting times, achievement of good HLA-matching and corresponding graft outIt is commonly assumed that patient acceptance polcome, optimal balance between national donor kidney icies for transplantation and time point in the evolution procurement and transplantation, and improved transof renal failure when patients are listed are similar for plant logistics aiming at short cold ischaemic times.
all patients in all centres. This is based on the consideraAll kidney offers would be made for a particular tion that all nephrologists act according to the latest patient. In a rather abrupt way the new allocation medical and scientific data. This is not true: everyone system attacked the distorted situation [5] that had will remember a patient who had been declined as a prevailed at the time of implementation, but now one transplant candidate in one centre and who was later gradually moves to a new steady state, closely following accepted for transplantation in another transplant the course predicted by the computer simulation studprogramme. ies. It is clear that a better trade-off between waiting
The indication for a kidney transplant is irreversible time, HLA-matching, and kidney donation/transend-stage renal failure, necessitating renal replacement therapy for patient survival. While a consensus is Correspondence and offprint requests to: Dr. G. G. Persijn, largely present on absolute contraindications, decision adversely influence the graft and/or patient outcome active kidney transplant waiting list, are responsible for the differences between countries. Austria and after transplantation. Such factors comprise re-transplantation, obesity, non-compliance, recur-Belgium have a kidney donation rate meeting about 40% of the active waiting list, in contrast to only 33% rence of primary end-stage renal disease, concurrent or past co-morbidity [6 ] . In 1992, Briggs [7] noted for The Netherlands and 20% for Germany. There may be other causes as well. Another ET study [10] considerable disparity in the selection criteria for transplantation in the United Kingdom. In 1998 a new analysed patients in The Netherlands with long waiting times (>5 years). It was concluded that the vast survey on the current criteria for the evaluation of adult candidates for a cadaveric renal transplant has majority of the patients were placed on the waiting list at the time the dialysis centre started its work-up of been carried out in Europe. It was coordinated by the renal transplant programme of Berlin Charité-the patient as a potential transplant candidate. The patients were listed as 'non-transplantable' until the Campus Mitte (personal communication, H. H. Neumayer, L. Fritsche). The results are eagerly patient has been fully assessed for, and accepted by, the transplant programme. The time the patient had awaited.
From an allocation-technical point of view, the point already spent on the waiting list, i.e. often 6-9 months, was counted as official waiting time. In other ET of time in the evolution of renal failure when the patient is listed as a transplant candidate is more countries, it is common practice to enter the patients on the waiting list only after they have been definitively crucial, since waiting time is an allocation factor in each kidney allocation system. It is often the sole accepted by the transplant programmes.
The wide variability in patient listing practices, which criterion to prioritize patients who are equally eligible for a donor kidney. In its most simple calculation, significantly affect allocation schemes makes it urgent to standardize criteria for defining the waiting time, waiting time is defined as the number of days the patients have accrued between the time of listing and the so-called minimal listing criteria [11] . A consensus conference on standardized listing criteria for renal the day of the kidney match run. Often, additional conditions alter this straightforward calculation of transplant candidates in the United States [12] reviewed scientific data concerning to the definition of waiting time. They may be time periods which are not counted as waiting time, e.g. as long as relevant match end-stage renal disease and the different handling of particular patient groups, e.g. diabetics or children. A data are absent ( ET ) or when the patient is (temporarily) not eligible for a transplant. The latter occurs in glomerular filtration rate of less than 18 ml/min (as calculated by a formula, using serum creatinine, age, the renal allocation procedure of the United Network for Organ Sharing ( UNOS-USA): as of the 30th day gender, race, serum urea nitrogen and serum albumin) would render a patient eligible for listing, and for of non-transplantability, the patient no longer accrues waiting time.
accrual of waiting time, if the patient has a progressive renal disease. Diabetes or other specific renal diseases Similar to late referral to dialysis units [8] , dialysis doctors might delay refering their patients to a trans-should not be handled differently, but care should be taken that children are not disadvantaged in any way. plant programme. Causes of such late referral include medical pathology such as significant intervening non-Similar discussions have started in Germany and The Netherlands, following the recent implementation of renal pathology such as a cardiovascular event or the occurrence of a tumour and its treatment, as well as their respective donation and transplant laws. A German proposal would allow pre-emptive entry on non-medical conditions, such as financial policies, lack of interest of the patient for social reasons or fear of the waiting list, starting at the moment when preparations for dialytic therapy are made (e.g. creation of an surgery or transplant complications. Listing prior to the start of dialysis (pre-emptive listing) has become AV-fistula). The pre-emptively listed patients could participate in the renal allocation procedure, although more and more popular. This is true in particular for transplanted patients with a failing graft, and also for they cannot obtain points for the allocation factor 'waiting time', since the accrual of waiting time is only paediatric patients. Better graft survival, and decreases in both growth failure and delay of neuropsychological possible at of the moment the patient has started with chronic dialytic treatment. Such a strategy might put development have been reported in children receiving a pre-emptive renal transplant [9] . Occasionally trans-patients who have opted for peritoneal dialysis and who receive their dialysis access rather late at a plant programmes list patients earlier than a transplant is actually required, in an effort to accrue waiting time. disadvantage.
As of January 2000, waiting time will be defined in In 1994, waiting time for cadaveric donor transplantation was analysed (personal analysis) using a the ET renal allocation system, as the time the patient has been dialysed, without interruption, regardless of competing risk analysis in a cohort of patients who entered the ET renal transplant waiting list in 1993. the therapeutic option i.e. haemodialysis or peritoneal dialysis. While this may seem fair for patients who There were striking differences between the ET countries: in Belgium and Austria 50% of the cohort was were referred late for transplantation or who have to wait to exclude recurrence of a tumour, this transplanted at 21 months, while the same transplant rate was obtained in The Netherlands at 36 months re-definition of waiting time might, contrary to its intention, promote late referral to a transplant proand in Germany at 40 months. It is likely that the differences in donor kidney availability, relative to the gramme, since patients are already accruing waiting time although they are not yet officially on the wait-volume: 2 vs 4-5% in the past. The relative frequency of the major indications has not changed, but new ing list.
In organ exchange organisations, another set of rules indications have been accepted: immuno-adsorption protocols, creation of a neo-bladder, and haemorrhagic deal with waiting time. If a patient has had an early kidney graft failure the waiting time, accrued prior to cystitis following kidney graft failure after a kidneypancreas transplantation, caused by a functional bladthis failed transplantation, would still be counted when the patient is re-listed for a repeat transplantation. The der-drained pancreas graft. It is important to note that the mortality on the HU renal transplant waiting list UNOS Kidney/Pancreas Transplantation Committee only allows for waiting time reinstatement under the is now virtually nil, in contrast to the early 1970s. The term 'High urgency' in renal transplantation no longer following conditions: (i) hyperacute rejection in the presence of a current negative cross-match, and (ii) stands for 'life-saving', in contrast to what is still true in cardiac and liver transplantation. graft failure due to non-immunological causes within the first 2 weeks. In contrast, the ET Kidney Advisory
The need for a HU category has regularly been questioned in the ET Kidney Advisory Committee. Committee has defined early kidney graft failure as any graft failure within the first 3 months post-The majority of the centres do not make a HU request, (i) because they want to adhere to their minimal HLAtransplant. Recently, the condition that such a patient has to be re-listed within 1 year after the failed renal antigen matching policy, (ii) because they want to avoid favouritism between patients and/or between transplant was dropped. It was felt to be clinically unsound to enforce such return on the waiting list. dialysis centres and (iii) because 'true life-saving' highly urgent conditions do no longer occur. Each time the Simultaneously, there was concern that-in view of the current tendency to use, more often, kidneys from final decision was to maintain the possibility of HU renal transplantation, but to limit the number of so-called marginal donors-any rule of waiting time reinstatement might encourage some transplant pro-patients per calendar year for whom a HU kidney transplant could be requested to no more than 1% of grammes to proceed with a transplantation against all odds. An audit of the cases of waiting time reinstate-the active waiting list of the previous year end. In the new ET kidney allocation system, the HU patients ment will therefore be indispensable.
It is clear that as an allocation factor, waiting time receive bonus points, enhancing the chance of appearing at the top of the allocation list. Waiting time is far from simple. It is even questionable as medical criterion. Therefore, proper and uniform guidelines for for a transplant, while the patient is on the HU waiting list, now averages 4 weeks. listing (and de-listing) should be defined.
Analysis of the HU patients who were transplanted during the period January 1, 1993 to March 10, 1996
High urgency kidney transplantation: old (n=161) confirmed the very inhomogeneous and
concept-new rule?
special nature of this population. In particular, the percentage of children (<16 years) was higher than expected (11 vs 3%), as was the percentage of The option 'highly urgent (HU ) kidney transplantation' goes back to the early days of dialysis and re-transplants (25 vs 17%). It was striking that the patients on the HU waiting list were not 'long-waiting' transplantation [13] . It implies rescue renal transplantation in order to keep the patient alive. In patients. The vast majority had been on the waiting list for less than 2 years (in case of a first transplant) exchange for a high priority HU kidney transplant, any preference for a minimum degree of HLA-match-or had a previous transplant functioning for less than 2 years. Up to 90% of the patients received a donor ing must be skipped. In the presence of a negative cross-match any kidney suitable for transplantation, kidney with zero or one HLA-DR mismatch.
The graft and patient survival is rather disapregardless of the HLA-matching, had to be accepted and transplanted. Imminent lack of haemodialysis pointing: the HU graft survival was 66% and 59% at 1 and 2 years respectively, with a patient survival at 2 access, often in combination with exhausted possibilities of or even contra-indications against peritoneal years of 84%. While the latter might still be an illustration of the life-saving effect of the rescue transplantadialysis, accounted for 60% of the HU requests. Severe polyneuropathy and/or inability to cope with the dia-tion, one could doubt whether this rescue transplant was truly worthwhile. lysis treatment-often accompanied by suicidal thoughts-accounted for another 20%. The remaining 20% was the result of a variety of conditions, such as ET senior programme: old-for-old concept severe renal osteodystrophy with metastatic calcifications, recurrent episodes of fluid overload, or poor general condition.
Transplantation is advocated as the best option of renal replacement therapy. Following the gradual Despite the marked advances of dialytic therapy, many transplant programmes in the ET area, even increase of elderly patients on dialysis [14], the same trend is noted in the field of transplantation [15] . In today, apply for the HU transplant option. The absolute number per year in the 1970s, 1980s and 1990s ET the number of patients aged 65 years or more who are registered for a first cadaveric renal transplant has remained similar, i.e. 60-70. Of course, today this represents a smaller fraction of the total transplant increased from 196 (4.7%) in 1993 to 301 (7.0%) in 1998, a 50% increase compared to the overall 5% isation of the procurement and transplant procedure, supplemented with high quality cross-matching, is increase.
Mortality inevitably increases with age. Therefore needed for the success of this endeavour. Also, close management of the elderly transplant candidates is a the chance of receiving a transplant while on the waiting list is potentially low for the elderly patient. conditio sine qua non, in view of their more frequent morbidity while on dialysis. Using a competing risk analysis technique, we compared the elderly patients (65+ years) and those aged 16-55 years, who were registered between 1992 and Immunological matching: matchability concept 1995. The major difference in outcome on the waiting list at 3 years was not the chance of transplantation (44% vs 47% in the elderly and young groups respect-The positive influence of HLA-matching on kidney graft survival has been demonstrated for more than 25 ively) but the risk of being removed because of poor condition or death. This risk was three times higher in years [20] [21] [22] . Realizing that a donor kidney with zero HLA-mismatches is only for the happy few, thresholds the elderly than in the young (32 vs 9%).
In addition, many registry reports indicate a lower of maximum mismatch and/or minimal sharing of HLA-antigens have been identified, as a proxy for a patient survival after transplantation for the elderly patient, although the kidney graft survival itself would 'optimal HLA-matching'. In this respect, it should be noted that between 1988 and 1996 the ET renal transnot be jeopardized (death with functioning graft) [16, 17] . In a time-dependent non-proportional Cox plant programmes were bound to the sharing of at least one HLA-B and one HLA-DR antigen. Even model [18] of elderly patients (65+ years) listed for transplantation between 1993 and 1996 in the ET area, today many transplant programmes continue to use these minimal requirements of HLA-matching, as is renal transplantation did not confer a survival benefit after 3 years of follow-up (personal communication, apparent from the centre-specific default HLA-matching profiles, stored in the ET kidney allocation Jacqueline Smits).
In response to the persistent shortage of donor programme.
What are the chances of receiving such a 'good kidneys, older donors are nowadays more carefully evaluated for potential kidney donation. One is aware HLA-matched' donor kidney (within a 'reasonable' waiting time)? For that purpose, several 'matchability' of an increased risk of initial non-function, and of lower short-term and long-term graft survival. or 'match prognostic' indexes [23] [24] [25] [26] [27] have been developed, expressing the relative likelihood of receivDecreased nephron mass, with a lesser functional reserve after an insult to the graft, e.g. rejection, ing a donor kidney with a 'good HLA-match'. These 'matchability' indexes help the transplant physician to delayed graft function or hyperfiltration, is presumably the main cause.
set the appropriate minimal HLA-match requirements, in relation to the patients HLA phenotype, and to Taking into consideration the intrinsically lower graft survival of an elderly donor kidney and the estimate the chances of a donor kidney, fulfilling these requirements. It goes without saying that if a HLAdecreased life-expectancy of an elderly recipient, several experts proposed the idea to establish a senior donor, match requirement is set too high then the patient will be eligible for few donor kidneys and will have to wait recipient pool: the 'old-for-old' programme. A retrospective UCLA study [19] provided evidence that such long for transplantation. And, in contrast, if it is set too low, the patient might experience a greater risk of a protocol was sensible. Seniors (61+ years) receiving kidneys of older donors (61+ years) tended to have graft failure or even death.
Information provided by the indexes should be interless graft failure compared to the younger recipients, while senior recipients of a younger donor kidney preted in the proper context. First, a kidney allocation programme is often not 100% HLA-matching driven; experienced a higher rejection rate compared to younger recipients. An effect of HLA-matching was other allocation factors are also involved.
Secondly, for the patient several donor HLA-antinot present in the group of senior recipients/senior donors. In an ET multivariate study investigating gens may be unacceptable, reducing substantially the number of 'good HLA-matched' donors. Regrettably, 1-year graft survival of the old-for-old couples while censoring for death with functioning graft, optimal there is no general consensus about the definition of unacceptable donor HLA-antigens. In any case, HLAresults were found in case of a first transplant of a non-sensitized elderly patient. specific antibodies, detected in the actual patient's serum, undoubtedly identify unacceptable donor HLA As of January 1, 1999, a prospective old-for-old allocation programme has been implemented in the Class I antigens and predict a positive crossmatch which is the final pre-transplant test. The relevance of ET organisation, the so-called ET Senior Programme. In practice, the transplant programme reporting an antibodies to the following is controversial: (i) HLA Class II HLA-antigens, (ii) HLA Class I antigens elderly donor (age 65+ years) has the possibility to select from the allocation list any local elderly patient which were identified only in historical sera, (iii) the donor HLA-antigens which were mismatched in previwho fulfills the following criteria: age 65 years or more, not sensitized and awaiting a first transplant. Since ous transplantations and, if applicable, (iv) the HLAantigens of the (sexual ) partner. All these additional short cold ischaemia times are thought to play a more important role than HLA-matching, an efficient organ-immunological restrictions affect almost 30% of the active ET kidney-only waiting list (n=11789; January tial aspects of kidney allocation systems. Continuous 1, 1999). Ideally, a 'matchability' index should also flexibility and solidarity of transplant programmes are consider the unacceptable donor HLA-antigens.
of the utmost importance if each transplant candidate Immunological matching is only relevant when there is to derive maximum benefit. is a sufficiently large donor catchment area [2] . The more donors, the higher the chance of a 'good' match. sufficient (graft and patient) survival benefit are essen-
